Mirae Asset Global Etfs Holdings Ltd. Pacira Bio Sciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,077 shares of PCRX stock, worth $622,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,077
Previous 25,283
3.14%
Holding current value
$622,197
Previous $380,000
29.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$126 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$77.9 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.9 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$47.5 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...